EXEL Exelixis Inc

Exelixis Inc is a part of the healthcare sector. As a biotechnology company, it develops small molecule therapies for the treatment of cancer.

$17.15  +0.50 (2.97%)
As of 07/28/2021 15:59:56 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/15/2001
Outstanding shares:  313,387,205
Average volume:  2,624,001
Market cap:   $5,174,022,755
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    30161Q104
ISIN:        US30161Q1040
Sedol:      2576941
Valuation   (See tab for details)
PE ratio:   53.90
PB ratio:   2.73
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy